Back
ImmunityBio Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
53
IBRX
ImmunityBio
Last Price:
5.04
Seasonality Move:
73.14%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.ImmunityBio Price Quote
$5.04
+0.00 (+3.38%)
(Updated: November 22, 2024 at 5:30 AM ET)
ImmunityBio Key Stats
Buy
53
ImmunityBio (IBRX)
is a Buy
Day range:
$4.84 - $5.15
52-week range:
$3.10 - $10.53
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
468.22
P/B ratio:
0%
Volume:
3.3M
Avg. volume:
8M
1-year change:
34.63%
Market cap:
$3.5B
Revenue:
$622K
EPS:
$-0.9
How Much Does ImmunityBio Make?
-
How Much Are ImmunityBio's Sales Annually?
IBRX Revenues are $622K -
How Much Profit Does ImmunityBio's Make A Year?
IBRX net income is -$583.2M
Is ImmunityBio Growing As A Company?
-
What Is ImmunityBio's Growth Rate Quarterly?
Quarterly YoY revenue growth is 73.46% -
What Is ImmunityBio's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
ImmunityBio Stock Price Performance
-
Did ImmunityBio Stock Go Up Last Month?
ImmunityBio share price went up by 41.83% last month -
Did IBRX's Share Price Rise Over The Last Year?
IBRX share price rose by 34.63% over the past 1 year
What Is ImmunityBio 52-Week High & Low?
-
What Is ImmunityBio’s 52-Week High Share Price?
ImmunityBio has traded as high as $10.53 over the past 52 weeks -
What Is ImmunityBio’s 52-Week Low Share Price?
ImmunityBio has traded as low as $3.10 over the past 52 weeks
ImmunityBio Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy ImmunityBio?
-
How Much Debt Does ImmunityBio Have?
Total long term debt quarterly is $699.1M -
How Much Cash Does ImmunityBio Have?
Cash and short term investments quarterly total is $130.4M -
What Is ImmunityBio’s Book Value Per Share?
Book value per share is -1.07
Is ImmunityBio Cash Flow Positive?
-
What Is IBRX Cash Flow From Operations?
Cash flow from operations (TTM) is -$421.4M -
What Is ImmunityBio’s Cash Flow From Financing?
Cash flow from financing (TTM) is $375.2M -
What Is ImmunityBio’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$19.8M
ImmunityBio Return On Invested Capital
-
Is Management Doing A Good Job?
IBRX return on invested capital is -963.14% -
What Is ImmunityBio Return On Assets?
ROA measures how assets are converting to revenues and is -136.92% -
What Is IBRX Return On Equity?
ROE is a measure of profitability and is 0%
ImmunityBio Earnings Date & Stock Price
-
What Is ImmunityBio's Stock Price Today?
A single share of IBRX can be purchased today for 5.04 -
What Is ImmunityBio’s Stock Symbol?
ImmunityBio trades on the nasdaq under the ticker symbol: IBRX -
When Is ImmunityBio’s Next Earnings Date?
The next quarterly earnings date for ImmunityBio is scheduled on May 9, 2025 -
When Is IBRX's next ex-dividend date?
ImmunityBio's next ex-dividend date is November 22, 2024 -
How To Buy ImmunityBio Stock?
You can buy ImmunityBio shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
ImmunityBio Competitors
-
Who Are ImmunityBio's Competitors?
Below is a list of companies who compete with ImmunityBio or are related in some way:
ImmunityBio Dividend Yield
-
What Is IBRX Dividend Yield?
ImmunityBio’s dividend yield currently is 0% -
What Is ImmunityBio’s Payout Ratio?
ImmunityBio’s payout ratio is 0% -
When Did ImmunityBio Last Pay A Dividend?
The latest dividend pay date is November 22, 2024 -
What Is ImmunityBio’s Dividend Per Share?
ImmunityBio pays a dividend of $0.00 per share
ImmunityBio Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 33.33% |
| Revenue: | 7346.34% | 108.75% |
Analyst Recommendations
| Buy Recommendations: | 2 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 14.25 |
| Upside from Last Price: | 183.02% |